These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8061340

  • 1. Serum soluble interleukin-2 receptor in pancreatic cancer and chronic pancreatitis.
    Pezzilli R, Billi P, Beltrandi E, Mancini R, Casadei-Maldini M, Casadei R, Greco VM, Campione O, Miglioli M.
    Ital J Gastroenterol; 1994 Apr; 26(3):137-40. PubMed ID: 8061340
    [Abstract] [Full Text] [Related]

  • 2. Soluble interleukin-2 receptor: a new marker in pancreatic adenocarcinoma?
    Rabitti PG, Pacelli L, Uomo G, Laccetti M, Spada OA, Esposito G, Visconti M.
    Minerva Gastroenterol Dietol; 1994 Sep; 40(3):101-3. PubMed ID: 7948318
    [Abstract] [Full Text] [Related]

  • 3. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
    Bodey B, Psenko V, Lipsey AL, Kaiser HE.
    Anticancer Res; 1996 Sep; 16(1):219-24. PubMed ID: 8615612
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W, Chyczewska E, Kovalchuk O, Tałałaj J, Izycki T, Panek B.
    Rocz Akad Med Bialymst; 2004 Sep; 49():246-51. PubMed ID: 15631351
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
    Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K.
    Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
    [Abstract] [Full Text] [Related]

  • 7. [Serum soluble IL-2 receptor level in patients with sarcoidosis].
    Ina Y, Takada K, Noda M, Satou T, Hashiba H, Miyachi A, Ito S, Iijima N, Yamamoto M.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar; 29(3):316-21. PubMed ID: 2067152
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Usefulness of the measurement of serum soluble IL-2 receptor alpha chain levels in clinical monitoring of non-Hodgkin lymphoma].
    Setoyama Y, Imai J, Ishikawa T, Sakaida H, Takaori-Kondo A, Kawamata S, Uchiyama T.
    Rinsho Byori; 1994 Aug; 42(8):834-42. PubMed ID: 7933620
    [Abstract] [Full Text] [Related]

  • 10. Serum levels of soluble interleukin-2 receptor in patients with ANCA-associated vasculitis.
    Arranz O, Ara J, Rodríguez R, Saurina A, Mirapeix E, Darnell A.
    J Nephrol; 2000 Aug; 13(1):59-64. PubMed ID: 10720216
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S, Shiota G, Kawasaki H.
    Hepatogastroenterology; 2003 Aug; 50(53):1569-74. PubMed ID: 14571788
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer.
    Barber MD, Fearon KC, Ross JA.
    Clin Sci (Lond); 1999 Jan; 96(1):83-7. PubMed ID: 9857110
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.